nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A morbillivirus causing mass mortality in seals
|
Osterhaus, Albert |
|
1989 |
7 |
6 |
p. 483-484 2 p. |
artikel |
2 |
Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination
|
Mäkelä, Mika J. |
|
1989 |
7 |
6 |
p. 541-545 5 p. |
artikel |
3 |
Antigenic protein used in malaria vaccine: cloned gene encoding Plasmodium malariae circumsporozoite protein
|
|
|
1989 |
7 |
6 |
p. 574- 1 p. |
artikel |
4 |
Anti-retroviral polypeptide sequence of human CD4 having an amino acid joined to a derivatizing group; used in HIV virus AIDS vaccine
|
|
|
1989 |
7 |
6 |
p. 574- 1 p. |
artikel |
5 |
Artificial HIV virus peptide having a sulphur bridge between two cysteine residues located on each side of a HIV epitope; useful as vaccine
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
6 |
Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine
|
Lydick, Eva |
|
1989 |
7 |
6 |
p. 549-553 5 p. |
artikel |
7 |
Author index, subject index
|
|
|
1989 |
7 |
6 |
p. 577-584 8 p. |
artikel |
8 |
Changes in the restriction endonuclease patterns of four modified-live infectious bovine rhinotracheitis virus (IBRV) vaccines after one passage in host animal
|
Whetstone, Cecelia |
|
1989 |
7 |
6 |
p. 527-532 6 p. |
artikel |
9 |
Characterization of the M protein and nucleoprotein genes of an avian influenza A virus which are involved in host range restriction in monkeys
|
Murphy, Brian R. |
|
1989 |
7 |
6 |
p. 557-561 5 p. |
artikel |
10 |
Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB
|
Tamura, Shin-ichi |
|
1989 |
7 |
6 |
p. 503-505 3 p. |
artikel |
11 |
Effects of formalin inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits
|
Duque, Hernando |
|
1989 |
7 |
6 |
p. 513-520 8 p. |
artikel |
12 |
Experimental-scale measles and mumps vaccine production on microcarrier-grown cells
|
Sidorenko, E.S. |
|
1989 |
7 |
6 |
p. 554-556 3 p. |
artikel |
13 |
Experimental studies on the protective efficacy of a Pseudomonas aeruginosa vaccine
|
Stanislavsky, E.S. |
|
1989 |
7 |
6 |
p. 562-566 5 p. |
artikel |
14 |
Expressing antigen in vertebrates by inoculation with recombinant virus-recombinant vaccine preparation; fowl-pox virus or canary-pox virus vector; antigen gene cloning and expression in Escherichia coli and mammal cell culture
|
|
|
1989 |
7 |
6 |
p. 574- 1 p. |
artikel |
15 |
Glutaraldehyde in whole-cell Bordetella pertussis vaccine
|
Arya, S.C. |
|
1989 |
7 |
6 |
p. 486- 1 p. |
artikel |
16 |
HIV virus incomplete particles comprise env gp120 or env gp160 proteins as main protein constituent with an optional p53-like substance, used as AIDS vaccine
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
17 |
Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
|
Murphy, Brian R. |
|
1989 |
7 |
6 |
p. 533-540 8 p. |
artikel |
18 |
Immunogenicity of a new type of yeast-derived hepatitis B vaccine consisting of M (pre-S2 + S) protein particles
|
Hazama, M. |
|
1989 |
7 |
6 |
p. 567-573 7 p. |
artikel |
19 |
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A
|
Richards, Roberta L. |
|
1989 |
7 |
6 |
p. 506-512 7 p. |
artikel |
20 |
Infectious cattle rhinotracheitis virus mutant, application as vaccine
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
21 |
Live Salmonella as vaccines and carriers of foreign antigenic determinants
|
Chatfield, Steven N. |
|
1989 |
7 |
6 |
p. 495-498 4 p. |
artikel |
22 |
Neisseria gonorrhoeae protein IA and IB gene sequence useful in gonorrhea recombinant vaccine production, disease diagnosis and therapy
|
|
|
1989 |
7 |
6 |
p. 574- 1 p. |
artikel |
23 |
New peptide containing the immunodominant epitope of pertussis toxin containing three specific regions of the S1 subunit, useful as vaccine and diagnostic; gene cloning and expression in Escherichia coli, Bacillus spp. or yeast
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
24 |
New Plasmodium falciparum antigens useful for recombinant vaccine and antibody production and diagnosis
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |
25 |
Pertussis vaccine and severe acute neurological illnesses
|
Miller, D.L. |
|
1989 |
7 |
6 |
p. 487-489 3 p. |
artikel |
26 |
Pertussis vaccines and permanent brain damage
|
Griffth, Dr A.H. |
|
1989 |
7 |
6 |
p. 489-490 2 p. |
artikel |
27 |
Postexposure rabies vaccination during pregnancy: experience with 21 patients
|
Chutivongse, Supawat |
|
1989 |
7 |
6 |
p. 546-548 3 p. |
artikel |
28 |
Prospects for the total eradication of rinderpest
|
Yilma, Tilahun D. |
|
1989 |
7 |
6 |
p. 484-485 2 p. |
artikel |
29 |
Recombinant fowl-pox virus strains containing DNA insert encoding heterologous protein, especially for recombinant vaccine production
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |
30 |
Recombinant HIV virus proteins: env gene cloning in plasmid vector and expression in Escherichia coli; AIDS vaccine preparation; DNA sequence
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
31 |
Recombinant vaccinia virus containing DNA of Japanese-encephalitis virus: recombinant vaccine preparation; antigenic surface protein gene cloning and expression; DNA sequence
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
32 |
Recombinant vaccinia virus containing flavi virus genes used in vaccine against flavi virus infections, especially dengue virus
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |
33 |
Recombinant vaccinia virus encephalitis-lethargica antigen gene cloning and expression; recombinant vaccine preparation
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |
34 |
Recombinant vaccinia virus: HIV virus tat protein gene cloning and expression in mammal cell culture; vector construction; potential recombinant vaccine and AIDS diagnosis
|
|
|
1989 |
7 |
6 |
p. 574- 1 p. |
artikel |
35 |
Serotyping Bordetella pertussis strains
|
Robinson, A. |
|
1989 |
7 |
6 |
p. 491-494 4 p. |
artikel |
36 |
Stability of recombinant vaccinia virus LC16m0 or LC16m8: Preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene
|
Watanabe, K. |
|
1989 |
7 |
6 |
p. 499-502 4 p. |
artikel |
37 |
Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines
|
Visser, I.K.G. |
|
1989 |
7 |
6 |
p. 521-526 6 p. |
artikel |
38 |
Vaccine against human parainfluenza virus type 3: recombinant vaccine preparation; vaccinia virus vector
|
|
|
1989 |
7 |
6 |
p. 576- 1 p. |
artikel |
39 |
Vaccine against infectious bovine keratoconjunctivitis containing cyanogen bromide cleavage fragments of pili of a pathogenic strain of Moraxella bovis
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |
40 |
Vaccine for protecting poultry against Escherichia coli septicemia contains F11-type fimbria, immunogenic section or antibody directed against them
|
|
|
1989 |
7 |
6 |
p. 575- 1 p. |
artikel |